Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 13.24%4.39B | 6.09%2.58B | -11.16%1.09B | 55.06%1.43B | -0.57%-706M | 33.57%3.88B | 7.95%2.43B | -8.01%1.23B | 566.50%919M | -43.85%-702M |
Net income from continuing operations | 103.02%4.17B | 336.26%1.26B | 9.50%1.03B | 15.76%940M | 12.11%944M | -58.01%2.06B | -125.72%-535M | 2.40%937M | -14.16%812M | -11.83%842M |
Operating gains losses | -872.81%-881M | -257.56%-542M | -48.68%-113M | -44.87%-113M | -48.68%-113M | 104.70%114M | 122.48%344M | 74.50%-76M | 73.91%-78M | 74.50%-76M |
Depreciation and amortization | 2.39%1.37B | 3.50%414M | 4.42%331M | 0.93%326M | 0.34%299M | -0.30%1.34B | 4.71%400M | -3.06%317M | -2.12%323M | -1.65%298M |
Deferred tax | 41.09%-582M | 71.74%-195M | -225.60%-157M | 41.74%-127M | 49.76%-103M | -207.79%-988M | -689.74%-690M | 420.51%125M | -10.10%-218M | -1.99%-205M |
Other non cash items | -104.82%-68M | -100.77%-12M | 97.64%-3M | -132.26%-10M | 21.82%-43M | 1,668.89%1.41B | 2,053.75%1.56B | -2,016.67%-127M | 342.86%31M | -400.00%-55M |
Change In working capital | 290.28%274M | 22.26%1.62B | -154.29%-19M | 1,723.81%383M | -12.13%-1.71B | 76.00%-144M | 5.58%1.33B | -91.38%35M | 102.09%21M | -21.61%-1.53B |
-Change in receivables | -110.96%-33M | 12.20%947M | 101.61%1M | -48.84%154M | -45.14%-1.14B | 143.62%301M | 3.30%844M | -146.97%-62M | 139.24%301M | 10.32%-782M |
-Change in inventory | -62.73%-358M | 4.55%184M | -121.54%-144M | 29.90%-136M | -91.24%-262M | -7.32%-220M | 617.65%176M | 10.96%-65M | -173.24%-194M | -407.41%-137M |
-Change in prepaid assets | 140.70%35M | 21.95%50M | 68.91%-60M | -103.33%-4M | 190.74%49M | -4,400.00%-86M | -37.88%41M | -8.43%-193M | 22.45%120M | -437.50%-54M |
-Change in payables and accrued expense | 553.24%630M | 66.29%439M | -48.17%184M | 279.13%369M | 34.42%-362M | -147.44%-139M | -34.98%264M | -32.38%355M | 22.85%-206M | -48.79%-552M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 13.24%4.39B | 6.09%2.58B | -11.16%1.09B | 55.06%1.43B | -0.57%-706M | 33.57%3.88B | 7.95%2.43B | -8.01%1.23B | 566.50%919M | -43.85%-702M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -10.56%-1.75B | -3.64%-798M | -80.50%-361M | -5.94%-321M | 12.94%-269M | -27.48%-1.58B | -33.22%-770M | -2.56%-200M | -38.36%-303M | -24.10%-309M |
Capital expenditure reported | 0.45%-1.77B | -1.62%-816M | -0.56%-361M | -5.26%-320M | 12.62%-270M | -23.69%-1.78B | -27.06%-803M | -21.28%-359M | -15.59%-304M | -26.64%-309M |
Net PPE purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | --0 | --0 | ---- | ---- | ---- | --197M | --40M | ---- | ---- | ---- |
Net other investing changes | 550.00%18M | ---- | ---- | ---- | --1M | -110.26%-4M | -600.00%-7M | 100.00%2M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -10.56%-1.75B | -3.64%-798M | -80.50%-361M | -5.94%-321M | 12.94%-269M | -27.48%-1.58B | -33.22%-770M | -2.56%-200M | -38.36%-303M | -24.10%-309M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 20.78%-1.4B | -18.96%-753M | 70.99%-676M | -427.11%-893M | -0.22%927M | 32.61%-1.76B | 16.93%-633M | -262.36%-2.33B | 146.35%273M | 250.08%929M |
Net issuance payments of debt | 164.02%2.5B | --0 | --0 | --0 | 25.06%2.5B | --945M | --0 | ---1.82B | --768M | --2B |
Net common stock issuance | -67.60%-2.51B | -27.46%-441M | -43.95%-321M | -170.19%-562M | -64.59%-1.19B | 0.27%-1.5B | 29.82%-346M | 39.89%-223M | 35.40%-208M | -127.36%-723M |
Cash dividends paid | -6.27%-1.19B | -6.03%-299M | -7.50%-301M | -6.69%-303M | -4.81%-283M | -6.08%-1.12B | -6.02%-282M | -4.87%-280M | -5.97%-284M | -7.57%-270M |
Net other financing activities | -111.11%-190M | -160.00%-13M | -500.00%-54M | -833.33%-28M | -30.14%-95M | -57.89%-90M | -66.67%-5M | -80.00%-9M | -400.00%-3M | -46.00%-73M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 20.78%-1.4B | -18.96%-753M | 70.99%-676M | -427.11%-893M | -0.22%927M | 32.61%-1.76B | 16.93%-633M | -262.36%-2.33B | 146.35%273M | 250.08%929M |
Net cash flow | ||||||||||
Beginning cash position | 20.64%3.11B | 59.75%3.33B | -3.31%3.27B | 22.69%3.06B | 20.64%3.11B | -27.00%2.58B | 24.97%2.08B | 189.48%3.38B | 14.77%2.5B | -27.00%2.58B |
Current changes in cash | 133.83%1.24B | 0.00%1.03B | 104.15%54M | -76.27%211M | 41.46%-48M | 155.82%532M | 12.73%1.03B | -361.97%-1.3B | 188.46%889M | 93.95%-82M |
End cash Position | 40.01%4.35B | 40.01%4.35B | 59.75%3.33B | -3.31%3.27B | 22.69%3.06B | 20.64%3.11B | 20.64%3.11B | 24.97%2.08B | 189.48%3.38B | 14.77%2.5B |
Free cash flow | 24.81%2.62B | 8.30%1.76B | -16.00%730M | 79.67%1.11B | 3.46%-976M | 43.25%2.1B | 0.49%1.63B | -16.36%869M | 233.70%615M | -38.11%-1.01B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |